+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Radiation Dose Management - Global Market Trajectory & Analytics

  • ID: 4805408
  • Report
  • April 2021
  • Region: Global
  • 174 pages
  • Global Industry Analysts, Inc
Global Radiation Dose Management Market to Reach $2.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Radiation Dose Management estimated at US$312.2 Million in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 36% over the period 2020-2027. Solutions, one of the segments analyzed in the report, is projected to record 33% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 41.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $94.2 Million, While China is Forecast to Grow at 34.1% CAGR

The Radiation Dose Management market in the U.S. is estimated at US$94.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$435.9 Million by the year 2027 trailing a CAGR of 34.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 33.1% and 30.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 24.3% CAGR.

Select Competitors (Total 42 Featured):
  • Agfa HealthCare
  • Bayer AG
  • Bracco Imaging SpA
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Medsquare
  • Novarad Corporation
  • PACSHealth LLC
  • Philips Healthcare
  • Qaelum N.V.
  • Sectra AB
  • Siemens Healthineers
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Radiation Dose Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Solutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Solutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Radiography & Mammography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Radiography & Mammography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Fluoroscopy and Interventional Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Fluoroscopy and Interventional Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Nuclear Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Nuclear Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Ambulatory Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Ambulatory Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 19: World Current & Future Analysis for Research Institutions and Academic Medical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World 7-Year Perspective for Research Institutions and Academic Medical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 21: USA Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 22: USA 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 23: USA Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: USA 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 25: USA Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: USA 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • CANADA
  • Table 27: Canada Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 28: Canada 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 29: Canada Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: Canada 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 31: Canada Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Canada 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • JAPAN
  • Table 33: Japan Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: Japan 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 35: Japan Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 36: Japan 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 37: Japan Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: Japan 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • CHINA
  • Table 39: China Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 40: China 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 41: China Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 42: China 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 43: China Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: China 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • EUROPE
  • Table 45: Europe Current & Future Analysis for Radiation Dose Management by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 46: Europe 7-Year Perspective for Radiation Dose Management by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 47: Europe Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 48: Europe 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 49: Europe Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 51: Europe Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 52: Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • FRANCE
  • Table 53: France Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 54: France 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 55: France Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: France 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 57: France Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 58: France 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • GERMANY
  • Table 59: Germany Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 60: Germany 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 61: Germany Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 62: Germany 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 63: Germany Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 64: Germany 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • ITALY
  • Table 65: Italy Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 66: Italy 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 67: Italy Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 68: Italy 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 69: Italy Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 70: Italy 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 71: UK Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 72: UK 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 73: UK Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 74: UK 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 75: UK Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 76: UK 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 77: Rest of Europe Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 78: Rest of Europe 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 79: Rest of Europe Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 80: Rest of Europe 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 81: Rest of Europe Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 82: Rest of Europe 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 83: Asia-Pacific Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 84: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 85: Asia-Pacific Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 86: Asia-Pacific 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 87: Asia-Pacific Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 88: Asia-Pacific 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
  • REST OF WORLD
  • Table 89: Rest of World Current & Future Analysis for Radiation Dose Management by Products & Services - Solutions and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 90: Rest of World 7-Year Perspective for Radiation Dose Management by Products & Services - Percentage Breakdown of Value Sales for Solutions and Services for the Years 2020 & 2027
  • Table 91: Rest of World Current & Future Analysis for Radiation Dose Management by Modality - Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 92: Rest of World 7-Year Perspective for Radiation Dose Management by Modality - Percentage Breakdown of Value Sales for Computed Tomography, Radiography & Mammography, Fluoroscopy and Interventional Imaging and Nuclear Medicine for the Years 2020 & 2027
  • Table 93: Rest of World Current & Future Analysis for Radiation Dose Management by End-Use - Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 94: Rest of World 7-Year Perspective for Radiation Dose Management by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Care Settings and Research Institutions and Academic Medical Centers for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 42
Note: Product cover images may vary from those shown
Adroll
adroll